Why the Market Still Prefers NeedlesFor Now Our program initiation data shows the markets route evolution clearly: Injectable GLP-1 programs have led the category for decades, with steady activity that accelerates sharply in the obesity era
December 15, 2025: MDL Created for Ozempic Vision Loss Lawsuits In a significant move, the Judicial Panel on Multidistrict Litigation has approved the creation of a new MDL for Ozempic vision loss lawsuits
The Precision Peptide Genetic Test does not predict response to any specific dose or medication
A Cleveland Clinic team led by cardiologist Amgad Mentias, MD, recently published a large database analysis showing that bariatric surgery in Medicare enrollees with obesity was associated with lower risk of mortality, new-onset heart failure and myocardial infarction ( J Am Coll Cardiol
Altogether, these results suggest effects at the epithelial/mucinlipid interface rather than a primary lacrimal-secretagogue mechanism
Wegovy HD self-pay price is $399/month through NovoCare Pharmacy